MediaPharma S.r.l.
A Company focused on the discovery and development of innovative drugs for the treatment of cancer and other diseases with unmet medical need.

MediaPharma Srl

MediaPharma Srl is a drug discovery biotech company active in immuno-oncology and focusing on research and development of humanized monoclonal antibodies, Antibody-Drug Conjugates (ADCs) and therapeutic proteins for treatment of cancer and other severe diseases with high medical need. Inherently innovative, MediaPharma focuses specially in those cancers that have become resistant to previous drug regimens. At MediaPharma, world-class researchers, biologists, doctors and entrepreneurs share the same values and have been working together for years.


Mediapharma has received investment from Filas Spa (Fondo di capitale di rischio) POR FESR 2007/2013, Italian Minister of Economic Development (Fondo Innovazione Tecnologica, FIT), POR FESR Abruzzo 2014-2020, POR FESR 2014-2020 Regione Lazio (Key Enabling Technologies, KET).